Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.5%
Thu, 19 Sep 9:20

AJANTA PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.5%Image source: Ivcandy/www.istockphoto.com

AJANTA PHARMA share price has plunged 10% and is presently trading at Rs 2,800.0.

Meanwhile, the BSE HEALTHCARE index is at 43,973.0 (up 0.5%).

Among the top losers in the BSE HEALTHCARE index today are J.B.Chemicals (down 1.4%) and SUVEN PHARMACEUTICALS (down 0.9%).

ASTER DM HEALTHCARE (up 3.8%) and ALEMBIC PHARMA (up 2.0%) are among the top gainers today.

Over the last one year, AJANTA PHARMA has moved up from Rs 1,664.7 to Rs 2,800.0, registering a gain of Rs 1,135.4 (up 68.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,973.0, registering a gain of 54.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 169.5%), SUVEN PHARMACEUTICALS (up 106.6%) and Lupin (up 95.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,359.2 (up 0.5%).

The top gainers among the BSE Sensex today are NTPC (up 2.8%) and HCl Tech. (up 1.7%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 25,487.1 (up 0.4%). NTPC and LTIMINDTREE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,359.2, registering a gain of 15,762.3 points (up 23.3%).

AJANTA PHARMA Financial Update...

AJANTA PHARMA net profit grew 18.1% YoY to Rs 2,458 million for the quarter ended June 2024, compared to a profit of Rs 2,081 million a year ago. Net sales rose 12.1% to Rs 11,449 million during the period as against Rs 10,210 million in April-June 2023.

For the year ended March 2024, AJANTA PHARMA reported 38.8% increase in net profit to Rs 8,162 million compared to net profit of Rs 5,880 million during FY23. Revenue of the company grew 12.5% to Rs 42,087 million during FY24.

The current Price to earnings ratio of AJANTA PHARMA, based on rolling 12 month earnings, stands at 41.0.


Equitymaster requests your view! Post a comment on "AJANTA PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.5%". Click here!